Russia Pharmaceutical Pricing & Reimbursement Guide 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Russia" report to their offering.

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered:

1. HEALTHCARE SYSTEM

Facts & Figures

Market Indicators

Provision & Funding

Reform Programme

Systemic Failure

New Priorities to 2025

2. PRICING

Prescription Drugs

Regulatory Bodies

Pricing Regulations

Amendments to Drug Law

DLO Pricing

Regional Schemes

Concerns about Withdrawal of Cheap Essential Drugs

Further Amendments to Pricing Methodology

Generic Drugs

Hospital Drugs

OTC Drugs

3. REIMBURSEMENT

Admission to Reimbursement

DLO Coverage

Previous Procedure

Other Public Schemes

Proposals for Further Amendments to Procedure

Plans for a Comprehensive National Reimbursement Scheme

Coverage of Rare Diseases

Reimbursement Categories

Reimbursement Prices

Hospital Reimbursement

Formularies

Funding

4. PHARMACOECONOMICS

Pharmacoeconomic Requirements

Integrated Analysis

Further Changes

Scientific Advice

Prior Position

5. PRICE BUILD UP

Wholesalers

Margins

Background

Retail Pharmacies

Margins

Background

Dispensing Doctors

Sales Tax

6. COST CONTAINMENT

Industry Paybacks

Promotional Costs

Patient Co-payments

Pharmaceuticals

Healthcare

Prescribing Controls

Treatment Standards

Electronic Platform

Hospital Prescribing

Reform Proposals

Generics

INN Prescribing

Generic Substitution

Counterfeits

7. FUTURE DEVELOPMENTS

Outlook

Plans for Roll-out of Drug Reimbursement System

Further Amendment to EDL, DLO Procedures

Further Amendments to Pricing Regulations

8. NAMES & ADDRESSES

For more information about this report visit http://www.researchandmarkets.com/research/jthppm/ims

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Pharmacoeconomics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Pharmacoeconomics